Stockholders' Equity (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|
Stock Options [Member] | ||||
Stockholders' Equity (Textual) | ||||
Stock-based compensation expense | $ 153,093 | $ 226,698 | $ 472,044 | $ 509,697 |
Stock based compensation expense included in net income of discontinued operations | 0 | 56,917 | 0 | 113,213 |
Unrecognized compensation expense | 748,737 | $ 748,737 | ||
Weighted average remaining vesting period | 1 year 10 months 2 days | |||
Restricted Stock [Member] | ||||
Stockholders' Equity (Textual) | ||||
Stock-based compensation expense | $ 0 | 80,925 | $ 82,345 | 160,931 |
Stock based compensation expense included in net income of discontinued operations | $ 13,712 | $ 27,273 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders. No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|